NLS Pharmaceutics AG
NLSP
$3.10
Closing
▼-8.55%
1D
▼-86.86%
YTD
NLSP
BBG00S2L2453
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $6.99/month
Market cap
$6.53M
Analysts' Rating
HOLD
Price Target (Mean)
0.00
Total Analysts
0
P/E
Operating Margin
0.00%
Beta
-0.56
Revenue Growth
0.00%
52 week high
$24.00
52 week low
$3.00
Div. Yield
%
EPS Growth
0.00
Company Profile
NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.
